From January 26 to 28, 2022, the Anhui Provincial Department of Agriculture and Rural Affairs’ Veterinary Drug GMP Acceptance Expert Group conducted an on-site inspection and acceptance of the new version of Veterinary Drug GMP at Anhui Keer Pharmaceutical Co., Ltd.

At the first meeting of veterinary drug GMP acceptance At the meeting, the quality director of Keer Pharmaceutical Company reported to the experts the operation status of the company’s new version of veterinary drug GMP. Subsequently, the expert group went deep into the production workshop, quality inspection room, and power workshop in strict accordance with the "Good Manufacturing Practice for Veterinary Drugs" (revised in 2020), "Measures for Inspection and Acceptance of Good Manufacturing Practice for Veterinary Drugs" and "Inspection and Acceptance Evaluation Standards for Good Manufacturing Practice for Veterinary Drugs" , water production room, raw materials, hazardous chemicals and finished product warehouses were comprehensively, rigorously and meticulously inspected, and relevant personnel were strictly assessed through on-site operations, meeting questions, etc.

After on-site inspection and document inspection , the expert group unanimously believed that: the company has clear quality objectives, a sound organizational structure, clear functions, and the personnel structure, quality and training meet the requirements; the environment of the factory and workshops meets the prescribed standards; the layout of the factory and production plants is reasonable, and the area, space and production process are consistent. Basically compatible; the environment, facilities and testing instruments of the quality inspection room basically meet the requirements; production management and material management meet the requirements, and quality control and assurance documents are basically complete. At the same time, the expert group put forward improvement suggestions for the deficiencies discovered during the inspection and acceptance process, hoping to implement them in a timely manner and make progress.

After full discussion by the expert group, it was unanimously recommended that Anhui Keer Pharmaceutical Co., Ltd.’s application for acceptance of veterinary small-volume terminal sterilization injection, veterinary powder premix, veterinary powder, veterinary powder, A total of nine production lines including oral liquid, veterinary breast and uterine infusion, veterinary traditional Chinese medicine extraction, veterinary tablet granules, veterinary solid disinfectant, and veterinary liquid disinfectant are veterinary drug GMP qualified production lines.

Keer Pharmaceutical Co., Ltd. passed the new version of veterinary drug GMP acceptance The implementation of veterinary drug GMP certification will place higher requirements on the production and quality management of enterprises. We will take this opportunity to more strictly standardize production and operations in accordance with the new version of veterinary drug GMP requirements, further scientifically and institutionalize production organization and quality management, produce high-quality products, provide high-quality services, and make greater contributions to the development of China's animal husbandry industry. contribution.